in Ann Oncol as of November 1, 2009 -- updated monthly
Most-cited rankings are recalculated at the beginning of the month.
Rankings are based on citations to articles on this journal site from articles in HighWire-hosted journals.
| 6. | W. De Roock, H. Piessevaux, J. De Schutter, M. Janssens, G. De Hertogh, N. Personeni, B. Biesmans, J.-L. Van Laethem, M. Peeters, Y. Humblet, E. Van Cutsem, S. Tejpar | ||
| KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab | |||
|---|---|---|---|
|
Ann Oncol Mar 01, 2008; 19: 508-515.
(In "Gastrointestinal tumors") |
|||
| 7. | D. Machover, E. Diaz-Rubio, A. de Gramont, A. Schif, J.-J. Gastiaburu, S. Brienza, M. Itzhaki, G. Metzger, D. N''Daw, J. Vignoud, A. Abad, E. François, E. Gamelin, M. Marty, J. Sastre, J.-F. Seitz, M. Ychou | ||
| Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines | |||
|
Ann Oncol Jan 01, 1996; 7: 95-98.
(In "Short report") |
|||
| 8. | E. Riboli | ||
| Nutrition and cancer: Background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC) | |||
|
Ann Oncol Dec 01, 1992; 3: 783-791.
(In "Special articles") |
|||
| 9. | K. Spaepen, S. Stroobants, P. Dupont, P. Vandenberghe, J. Thomas, T. de Groot, J. Balzarini, C. De Wolf-Peeters, L. Mortelmans, G. Verhoef | ||
| Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkins lymphoma | |||
|
Ann Oncol Sep 01, 2002; 13: 1356-1363.
(In "Hematologic malignancies") |
|||
| 10. | N. L. Harris, E. S. Jaffe, J. Diebold, G. Flandrin, H. K. Muller-Hermelink, J. Vardiman, T. A. Lister, C. D. Bloomfield | ||
| The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November, 1997 | |||
|
Ann Oncol Dec 01, 1999; 10: 1419-1432.
(In "Commentaries") |
|||
| [Previous 5 Articles] [Next 5 Articles] | |||